FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Profit Before Tax | ₹35 Cr | ₹27 Cr |
| Adjustment | ₹46 Cr | ₹28 Cr |
| Changes In working Capital | ₹-69 Cr | ₹-72 Cr |
| Cash Flow after changes in Working Capital | ₹12 Cr | ₹-17 Cr |
| Cash Flow from Operating Activities | ₹12 Cr | ₹-17 Cr |
| Cash Flow from Investing Activities | ₹-74 Cr | ₹-6.35 Cr |
| Cash Flow from Financing Activities | ₹121 Cr | ₹27 Cr |
| Net Cash Inflow / Outflow | ₹60 Cr | ₹3.70 Cr |
| Opening Cash & Cash Equivalents | ₹5.22 Cr | ₹1.52 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹65 Cr | ₹5.22 Cr |
Compare Cashflow Statement of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹2,379.0 Cr | -9.2% | 5% | 189.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -9.2% |
5% |
189.6% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses